Hair-cycle-dependent expression of parathyroid hormone-related protein and its type i receptor: Evidence for regulation at the anagen to catagen transition
Cho YM, Woodard GL, Dunbar M et al. (2003) Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: evidence for regulation at the anagen to catagen transition. J Investig Dermatol Symp Proc 120:715-27
Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development
Foley J, Dann P, Hong J et al. (2001) Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development 128:513-25
Parathyroid hormone-related peptide and the hair cycle-is it the agonists or the antagonists that cause hair growth?
Gensure RC (2014) Parathyroid hormone-related peptide and the hair cycle-is it the agonists or the antagonists that cause hair growth? Exp Dermatol 23:865-7
Beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin
Huelsken J, Vogel R, Erdmann B et al. (2001) beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105:533-45
Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen- targeted parathyroid hormone analog, in a non-depilated mouse model
Katikaneni R, Ponnapakkam T, Matsushita O et al. (2014) Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen- targeted parathyroid hormone analog, in a non-depilated mouse model. Anticancer Drugs 25:30-8
Treatment for chemotherapy- induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain
Katikaneni R, Ponnapakkam T, Suda H et al. (2012) Treatment for chemotherapy- induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain. Int J Cancer 131: E813-21
Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009
Mirzoyev SA, Schrum AG, Davis MD et al. (2013) Lifetime incidence risk of alopecia areata estimated at 2. 1% by Rochester Epidemiology Project, 1990-2009. J Investig Dermatol Symp Proc 2013:464